Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Abvc Biopharma (ABVC) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Abvc Biopharma (ABVC) over the last 9 years, with Q3 2025 value amounting to $527.0.

  • Abvc Biopharma's Tax Provisions rose 4845.07% to $527.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $24509.0, marking a year-over-year decrease of 6156.78%. This contributed to the annual value of -$110539.0 for FY2024, which is 14317.83% down from last year.
  • According to the latest figures from Q3 2025, Abvc Biopharma's Tax Provisions is $527.0, which was up 4845.07% from $23627.0 recorded in Q2 2025.
  • In the past 5 years, Abvc Biopharma's Tax Provisions registered a high of $1.0 million during Q4 2021, and its lowest value of -$110894.0 during Q2 2024.
  • In the last 5 years, Abvc Biopharma's Tax Provisions had a median value of $355.0 in 2024 and averaged $119494.9.
  • Per our database at Business Quant, Abvc Biopharma's Tax Provisions surged by 127039.41% in 2021 and then plummeted by 23574.15% in 2024.
  • Over the past 5 years, Abvc Biopharma's Tax Provisions (Quarter) stood at $1.0 million in 2021, then dropped by 4.79% to $962874.0 in 2022, then plummeted by 81.79% to $175310.0 in 2023, then crashed by 99.8% to $355.0 in 2024, then surged by 48.45% to $527.0 in 2025.
  • Its last three reported values are $527.0 in Q3 2025, $23627.0 for Q2 2025, and $355.0 during Q3 2024.